Reduction of postprandial hyperglycemia in patients with type 2 diabetes reduces NF-kappaB activation in PBMCs.
Rudofsky G Jr, Reismann P, Schiekofer S, Petrov D, von Eynatten M, Humpert PM, Isermann B, Müller-Hoff C, Thai TP, Lichtenstein S, Bärtsch U, Hamann A, Nawroth P, Bierhaus A.
Rudofsky G Jr, et al. Among authors: reismann p.
Horm Metab Res. 2004 Sep;36(9):630-8. doi: 10.1055/s-2004-825904.
Horm Metab Res. 2004.
PMID: 15486815
Clinical Trial.